November 13, 2007in IP, Patents, Pharmaceutical Drugs1by Editor566 Novartis challenges Indian IP law A Swiss pharmaceutical company, Novartis, sought to have the January 2006 decision to reject its patent application for the cancer drug imatinib mesylate (Gleevec) reversed by the Chennai High Court…
